CD4 and infection: ART was first recommended by the World Health Organisation (WHO) for HIV-infected patients with moderate and advanced stages of infection, at a CD4 count ≤200 cells/μL in 2002 [4] and a CD4 count ≤350 cells/μL in 2010 [5].